These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30742392)

  • 1. [Recurrence prevention for urinary stone disease. Part II.The factors associated with increase in incidence of urinary stone disease. Current views on the mechanisms of stone formation (continuation)].
    Saenko VS; Gazimiev MA; Pesegov SV; Alyaev YG
    Urologiia; 2018 Dec; (6):131-138. PubMed ID: 30742392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methanaphylaxis of urolithiasis. Part 3. The factors associated with increase in incidence of urinary stone disease. Current views on the mechanisms of stone formation].
    Saenko VS; Gazimiev MA; Pesegov SV; Alyaev YG
    Urologiia; 2019 Apr; (1):105-112. PubMed ID: 31184027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methanaphylaxis of urolithiasis. Part 1. Factors for increasing incidence of urolithiasis. Current theories of renal stone formation].
    Saenko VS; Gazimiev MA; Pesegov SV; Alyaev YG
    Urologiia; 2018 Oct; (4):161-169. PubMed ID: 30761808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary stone disease. Part IV. Recurrence prevention for urinary stone disease].
    Saenko VS; Gazimiev MA; Pesegov SV; Alyaev YG
    Urologiia; 2019 Jun; (2):88-96. PubMed ID: 31162908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm.
    Tiselius HG; Daudon M; Thomas K; Seitz C
    Eur Urol Focus; 2017 Feb; 3(1):62-71. PubMed ID: 28720369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interdisciplinary approach for prevention of recurrent urinary stone disease].
    Saenko VS; Pesegov SV
    Urologiia; 2020 Nov; (5):87-92. PubMed ID: 33185354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors determining active urinary stone formation in patients with urolithiasis.
    Netelenbos JC; Zwijnenburg PJ; ter Wee PM
    Clin Nephrol; 2005 Mar; 63(3):188-92. PubMed ID: 15786819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
    Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C
    Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies on recurrence of urolithiasis. (2) Hypercalciuria and recurrence of urolithiasis].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Nov; 33(11):1766-71. PubMed ID: 3445858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The evaluation of patients with urinary calculi discloses disturbances of metabolism in 75% of all cases (author's transl)].
    Rummelhardt S; Zechner O
    Wien Klin Wochenschr; 1979 Aug; 91(15):503-9. PubMed ID: 473769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of verapamil on urinary stone-forming risk factors.
    Sarica K; Erturhan S; Altay B
    Urol Res; 2007 Feb; 35(1):23-7. PubMed ID: 17165082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic disturbances in Chinese children with urolithiasis: a single center report.
    Yang D; Tiselius HG; Lan C; Chen D; Chen K; Ou L; Liu Y; Xu S; Zeng G; Lei M; Wu W
    Urolithiasis; 2017 Jun; 45(3):285-290. PubMed ID: 27510800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric urolithiasis--evaluation of risk factors in 95 children.
    Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K
    Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirty-eight years of stone meetings in Europe.
    Bichler KH
    Urol Res; 2006 Apr; 34(2):70-8. PubMed ID: 16506036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
    Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
    Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Characteristics and Risks Associated with Stone Recurrence in Korean Young Adult Stone Patients.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Kim WJ; Lee SC
    J Endourol; 2017 Aug; 31(8):806-811. PubMed ID: 28537440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and stones.
    Sarica K
    Curr Opin Urol; 2019 Jan; 29(1):27-32. PubMed ID: 30308572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.